PNC Financial Services Group
LSTA icon

PNC Financial Services Group’s Lisata Therapeutics LSTA Stock Holding History

PNC Financial Services Group’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-5
Closed – – 4143
2016
Q2 		$0 Buy
+5
New +$460 ﹤0.01% 4529

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

PNC Financial Services Group's LSTA Position: Q3 2016 in Review

PNC Financial Services Group sold out of Lisata Therapeutics (LSTA) in Q3 2016, closing a stake of 5 shares.

PNC Financial Services Group first reported a position in LSTA in Q2 2016 and held it in 1 quarter. The position peaked at $0 in Q2 2016. 28 funds tracked by Wall St. Rank hold LSTA as of Q3 2016.

  • PNC Financial Services Group reported no remaining Lisata Therapeutics position as of Q3 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 5 Lisata Therapeutics shares in Q3 2016.
  • PNC Financial Services Group first reported a position in Lisata Therapeutics in Q2 2016 and held it in 1 quarter.
  • PNC Financial Services Group's Lisata Therapeutics position peaked at $0 in Q2 2016.
  • 28 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2016.

Based on PNC Financial Services Group's 13F filing for Q3 2016, filed 4 Nov 2016.